Slate Path Capital LP - Q3 2023 holdings

$3.59 Billion is the total value of Slate Path Capital LP's 50 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .

 Value Shares↓ Weighting
ExitBIRD GLOBAL INC*w exp 99/99/999$0-120,000
-100.0%
0.00%
ExitWEWORK INCcl a$0-8,903,705
-100.0%
-0.08%
PSTG ExitPURE STORAGE INCcl a$0-225,000
-100.0%
-0.30%
PTON ExitPELOTON INTERACTIVE INC$0-1,980,000
-100.0%
-0.56%
SNAP ExitSNAP INCcl a$0-1,460,000
-100.0%
-0.63%
WMG ExitWARNER MUSIC GROUP CORP$0-1,609,779
-100.0%
-1.54%
ExitNOBLE CORP PLC$0-1,064,000
-100.0%
-1.61%
AMD ExitADVANCED MICRO DEVICES INC$0-775,000
-100.0%
-3.23%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings